The agency cited quality issues at facilities testing Dexcom’s G6 and G7 monitors, including inadequate validation and risk ...
Dexcom made a significant design change to a component used in its sensors and did not adequately validate the change, ...
Dexcom’s investigational 15-day continuous glucose monitor has a lower mean absolute relative difference than the current ...
A company spokesperson said Dexcom plans to resolve the agency's concerns but stated no design changes were made to its ...
The general mood among these heavyweight investors is divided, with 12% leaning bullish and 50% bearish. Among these notable ...
Jake Leach caught up with MedTech Dive during the ATTD conference to discuss new data on the company’s glucose monitors and ...
Nanowear, a leader in home-based cardiometabolic digital diagnostics announced that SimpleSense™, a nanotechnology-enabled wearable, mobile and software diagnostics platform, will ingest glucose data ...
Medical device companies presented new data this week at the Advanced Technologies & Treatments for Diabetes conference.
CGMs are transforming health tracking for non-diabetics, providing insights into glucose levels and influencing dietary choices and athletic performance.
8d
First for Women on MSNMDs Share 5 Things To Know About Blood Sugar Monitors—Even if You Don't Have DiabetesThe latest trend in health and fitness tracking may sound familiar: wearing continuous glucose monitors (CGMs). Many people ...
The Joseph P. Addabbo Family Health Center (JPAFHC) in Southeast Queens is making significant strides in diabetes care in New ...
will ingest glucose data from Dexcom G7 Continuous Glucose Monitoring Systems (CGM) time synchronously alongside Nanowear’s previously FDA cleared cardiovascular biomarkers. The continuous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results